Study examines pre-injury status in evaluating ACL repairs | Brain organoids cultured from stem cells for toxicity tests | N.H. DMV recognized for donor registration
September 23, 2015
AATB SmartBrief
News for the Tissue Banking Community

Top Story Sponsored By
Study examines pre-injury status in evaluating ACL repairs
A 313-patient, prospective study suggested that the pre-injury status and not just preoperative status needs to be considered in evaluating the result of anterior cruciate ligament reconstructions. Patients on average reported improved function following surgery compared with their pre-operative status but not compared with their pre-injury status, according to findings presented at a meeting of the British Orthopaedic Association. Recall bias may be an obstacle to determining pre-injury status, and the study includes multiple reconstruction techniques, the researchers said. Healio (free registration)/Orthopedics Today (9/17)
Share: LinkedInTwitterFacebookGoogle+Email
These two organizations have jointly developed a standalone system for labeling corneas. The purpose is to ensure that by January 2017, member eye banks are ISBT 128 compliant. "Since we created this 2017 mandate for our members, it was important to me that we also gave our members a way to fulfill these requirements," said Kevin Corcoran, EBAA's president and CEO. Learn more
Tissue Banking in the News
Brain organoids cultured from stem cells for toxicity tests
Scientists with the University of Wisconsin-Madison reported in the Proceedings of the National Academy of Sciences that they have grown tiny, three-dimensional brain organoids that include neurons, glial cells, microglia and vascular cells for use in screening chemicals for neurotoxicity. In tests of the cells with 10 known chemicals, the model correctly identified all but one as safe or toxic to fetal brain development. Forbes (9/21), Milwaukee Journal Sentinel (tiered subscription model) (9/21)
Share: LinkedInTwitterFacebookGoogle+Email
N.H. DMV recognized for donor registration
The American Association of Motor Vehicle Administrators and the New England Organ Bank have honored New Hampshire's Division of Motor Vehicles for achieving the highest rate of tissue and organ donor designation in the Northeast. The state's DMV has a 53.8% donor designation rate, according to the association. WMUR-TV (Manchester, N.H.)/The Associated Press (9/17)
Share: LinkedInTwitterFacebookGoogle+Email
Government & Regulatory
CDC backs efforts against Chagas' disease in South Texas
Researchers with the University of Texas Health Science Center at Houston School of Public Health have received a five-year, $544,329 grant from the Centers for Disease Control and Prevention for education and outreach about Chagas' disease in South Texas. The team, along with health care providers, is seeking to raise awareness about the disease, its prevention and treatment. The goals include reaching community and military groups that spend time in high-risk outdoor areas. BioNews Texas (9/17)
Share: LinkedInTwitterFacebookGoogle+Email
Bill to delay direct supervision rule gets Senate OK
The US Senate approved the Protecting Access to Rural Therapy Services Act that delays until the end of 2015 CMS implementation of a direct supervision policy for hospital outpatient therapeutic services. Bill sponsors said that the rule would threaten access to care in rural areas and that general supervision by a physician or nonphysician health care professional is enough to warrant payment of the hospital outpatient services. HealthLeaders Media (9/15)
Share: LinkedInTwitterFacebookGoogle+Email
Lonza expands stem cell pipeline
Lonza is now offering its line of human bone-marrow-derived mesenchymal stem cells for use in translational and cell therapy research. The cells are available in three types that will differentiate into chondrogenic, adipogenic and osteogenic lineages when cultured. (9/21)
Share: LinkedInTwitterFacebookGoogle+Email
Professional groups urge HHS to delay stage 3 MU
An alliance of more than 40 health care organizations including the American Medical Association is urging the federal government to delay the final stage of the meaningful use program. In letters to HHS Secretary Sylvia Mathews Burwell and Office of Management and Budget Director Shaun Donovan, the groups asked for a reassessment of standards developed before the approval of the Medicare Access and CHIP Reauthorization Act. Obstacles to interoperability and usability could hinder EHR users' ability to make payment reforms under the law. (9/18)
Share: LinkedInTwitterFacebookGoogle+Email
FDA OKs bone graft from Wright Medical
The Augment Bone Graft, developed by Wright Medical as a substitute to autograft for hind foot and ankle fusion, has received approval from the FDA. The product is made up of beta-tricalcium phosphate and recombinant human platelet-derived growth factor. (9/22)
Share: LinkedInTwitterFacebookGoogle+Email
Meniscal repair system from Ceterix is cleared by FDA
The FDA approved Ceterix Orthopaedics' NovoStitch Plus meniscal repair system intended for the treatment of complex meniscal tears. Previous studies showed sutures with the device had comparable or superior strength than sutures done with open surgeries. (9/22)
Share: LinkedInTwitterFacebookGoogle+Email
Register now for the September AATB Webinar!
  • Topic: The Where and Why of Postmortem Toxicology: Specimen Collection to Lab Result and How Things Can Go Wrong.
  • Speaker: Dr. Ruth Winecker, Ph.D.
  • Date: Tuesday, Sept. 29
  • Time: 2-3 p.m. (ET)
Read more and register.
Share: LinkedInTwitterFacebookGoogle+Email
Join AATB as an Affiliate Member
Are you a manufacturer, supplier, shipping, packaging, laboratory or storage organization and NOT eligible for AATB Accreditation? Your organization can now join AATB as an Affiliate Member! Contact AATB Director of Membership and Marketing Jamien Payne at for more details today.
Share: LinkedInTwitterFacebookGoogle+Email
It is not the man who has too little, but the man who craves more, that is poor."
-- Seneca,
Share: LinkedInTwitterFacebookGoogle+Email
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
Advertising:  Meryl Harold
  P: 202.407.7828
Editor:  Tom Parks

Download the SmartBrief App  iTunes / Android
iTunes  Android
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2015 SmartBrief, Inc.®
Privacy policy |  Legal Information